Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.22 +0.61 (+0.82%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Other Operating Expenses (2021 - 2026)

Updated

Kiniksa Pharmaceuticals International's Other Operating Expenses was $111.64 million in Q2 2026, up 57.2% from $71.02 million a year earlier and up 15.8% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Other Operating Expenses (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Kiniksa Pharmaceuticals International's Other Operating Expenses was $382.55 million through Jun 30, 2026, up 54.1% year-over-year; for FY2025, it came in at $307.22 million, up 62.4% from FY2024.

  • Other Operating Expenses has now increased for three consecutive years, with a four-year compound annual growth rate of 338.0% (FY2021 to FY2025).
  • In earlier years, Other Operating Expenses was $189.22 million in FY2024 (+110.4%), $89.93 million in FY2023 (+91.5%), $46.97 million in FY2022 and $835,000 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Other Operating Expenses in data going back to Q2 2021.
  • Compared with a year earlier, Other Operating Expenses has increased for 17 straight quarters, with growth averaging 77.6% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Other Operating Expenses ranged from 22.9% (Q1 2023) to 317.8% (Q3 2022).
  • Per Business Quant data, KNSA's Other Operating Expenses in the three quarters before Q2 2026 was $96.37 million (Q1 2026), $90.98 million (Q4 2025) and $83.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kiniksa Pharmaceuticals International 11.64 Bn 10.38 Bn 220.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 111.64 Mn
Mar 31, 2026 96.37 Mn
Dec 31, 2025 90.98 Mn
Sep 30, 2025 83.56 Mn
Jun 30, 2025 71.02 Mn
Mar 31, 2025 61.66 Mn
Dec 31, 2024 66.09 Mn
Sep 30, 2024 49.42 Mn
Jun 30, 2024 42.34 Mn
Mar 31, 2024 31.38 Mn
Dec 31, 2023 26.52 Mn
Sep 30, 2023 26.40 Mn
Jun 30, 2023 21.69 Mn
Mar 31, 2023 15.32 Mn
Dec 31, 2022 14.23 Mn
Sep 30, 2022 11.56 Mn
Jun 30, 2022 8.70 Mn
Mar 31, 2022 12.47 Mn
Dec 31, 2021 4.70 Mn
Sep 30, 2021 2.77 Mn
API Access

Kiniksa Pharmaceuticals International Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=KNSA&period=max&api_key=YOUR_API_KEY